Nouri Alaleh 4

What Happened Nouri Alaleh, EVP, Chief Legal Officer and Corporate Secretary of PROCEPT BioRobotics (PRCT), sold a total of 5,363 shares in open-market transactions on March 19, 2026 for combined proceeds of $139,230. The sales were split into two groups: 3,031 shares at a weighted average price of $25.82 (proceeds $78,258) and 2,332 shares at a weighted average price of $26.15 (proceeds $60,972). These were sales (not purchases).

Key Details

• Transaction date: 2026-03-19 (reported same day)
• Sales: 3,031 shares @ weighted avg $25.82 (range $25.025–$26.020) — $78,258; 2,332 shares @ weighted avg $26.15 (range $26.025–$26.450) — $60,972
• Total sold: 5,363 shares for $139,230
• Shares owned after transaction: not provided in the supplied filing information
• Footnotes: Sales were executed pursuant to a Rule 10b5-1 trading plan adopted June 4, 2025; weighted average prices reported with ranges, and the filer will provide per-price breakdowns on request
• Filing timeliness: Reported on the same date as the transactions (no late filing indicated)

Context These sales were made under a pre-established 10b5-1 trading plan, which allows insiders to sell shares according to a predetermined schedule and is commonly used to avoid trading on nonpublic information. Such planned sales are typically considered routine and do not, by themselves, indicate management’s current view on the company’s prospects.